Streetbeat News

Regulatory

COIN

The SEC has stated that Coinbase's staking program includes five stakeable crypto assets, classifying the program as an investment contract and therefore a security.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 12:30 pm

MARA

MSTR

RIOT

Crypto-related stocks are trading lower after the SEC sued Coinbase in New York federal court, potentially affecting companies like MARA, MSTR, and RIOT.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 12:27 pm

COIN

The SEC has stated that the crypto assets offered on Coinbase's platform place the company's operations under the purview of securities laws, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 12:23 pm

IBM

IBM plans to open its first European quantum data center in Ehningen, Germany, serving IBM Quantum's European cloud region. The facility will help clients manage European data regulation requirements and provide access to advanced quantum computing. The data center is expected to be operational in 2024.

Portfolio Pulse from Lekha Gupta

June 06, 2023 | 12:22 pm

RVYL

RYVYL EU has received approval to launch Single Euro Payments Area (SEPA) instant payments in Europe, enabling faster and more efficient transactions across the region.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 12:09 pm

PTGX

Protagonist Therapeutics has reported the acceptance of a late-breaking abstract for an oral presentation at the 2023 European Hematology Association (EHA) Congress. The EHA will also feature two additional presentations from the company's rusfertide peptide therapeutic development program, including new data and updates in polycythemia vera.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 11:35 am

SFIX

Stitch Fix has been granted U.S. Patent #11669776 for using artificial intelligence (AI) to design products. This technology could potentially revolutionize the company's approach to personalized fashion and improve customer experience.

Portfolio Pulse from Charles Gross

June 06, 2023 | 11:12 am

TCRX

TScan Therapeutics has received FDA clearance for its Investigational New Drug (IND) application for TSC-200-A0201, targeting HPV16 to treat solid tumors. This marks a significant milestone for the company's TCR-T cell therapy program.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 11:05 am

MRK

The FDA has approved a new indication for Merck's Prevymis (Letermovir) for prophylaxis of cytomegalovirus (CMV) disease in adult kidney transplant recipients at high risk. Prevymis is an antiviral agent initially approved in 2017 for CMV-seropositive recipients of allogeneic hematopoietic stem cell transplants.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 10:52 am

FXI

Chinese regulators have asked major state-owned banks to lower dollar deposit rates by up to 100 basis points to 4.3%, according to Reuters sources.

Portfolio Pulse from Charles Gross

June 06, 2023 | 10:46 am